Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2005, No. 04
(2005; 15 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsFEATURE

WHO Pharmaceuticals Newsletter 2005, No. 04

prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden

The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of "drug information officers" and other sources such as specialized bulletins and journals, as well as partners in WHO. The information is produced in the form of résumés in English, full texts of which may be obtained on request from:

Quality Assurance and Safety:

Medicines, PSM-HTP
World Health Organization,
1211 Geneva 27, Switzerland
E-mail address: pals@who.int

This newsletter is also available on our Internet website: http://www.who.int/medicines Further information on adverse reactions may be obtained from the WHO Collaborating Centre for International Drug Monitoring, Stora Torget 3, 753 20 Uppsala, Sweden

Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org

News & Issues

This issue comes to you close on the heels of the recently concluded Annual meeting of national pharmacovigilance centres here in Geneva. Over forty countries were represented, with the WHO venue providing the perfect opportunity to promote pharmacovigilance within several public health programmes: of interest were the interactions with HIV/AIDS, malaria, helminths and the tuberculosis programmes. Working group exercises on these topics and the sessions on vaccines, patient safety, and classification systems highlighted the future trends and issues in pharmacovigilance. The guest lecture 'Patient safety: a global challenge' by Sir Liam Donaldson, Chief Medical Officer, United Kingdom and Chair of the World Alliance for Patient Safety, was significant in highlighting the common concerns across professions in promoting patient care. It is clear that future efforts will have to build on collaborations, given the widening scope and expanding role of pharmacovigilance. We take the opportunity to thank all the participants for their enthusiasm and active participation while summarizing the recommendations from three of the working group exercises.

© World Health Organization 2005

All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

This publication contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization.


to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017